CILICAINE SYRINGE 1.5 procaine benzylpenicillin (procaine penicillin) 1.5g injection syringe Australia - English - Department of Health (Therapeutic Goods Administration)

cilicaine syringe 1.5 procaine benzylpenicillin (procaine penicillin) 1.5g injection syringe

viatris pty ltd - procaine benzylpenicillin, quantity: 1.5 g - injection, suspension - excipient ingredients: sodium citrate dihydrate; water for injections; polysorbate 80 - indications as at 18 february 2002: treatment of moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests and also by clinical response. infections which usually respond to adequate dosage are: group a streptococcal infections including upper respiratory tract infections, skin and skin structure infections and scarlet fever; pneumococcal infections of the respiratory tract; susceptible staphylococcal infections, most gonococcal infections, syphilis, fusospirochaetosis (vincent's gingivitis and pharyngitis). cilicaine syringe 1.5 must be administered by the intramuscular route only (see section 4.2 dose and method of administration).

DUPLOCILLIN PROCAINE AND BENZATHINE PENICILLIN INJECTION Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

duplocillin procaine and benzathine penicillin injection

intervet australia pty limited - procaine penicillin; benzathine penicillin - parenteral liquid/solution/suspension - procaine penicillin antibiotic-penicillin active 150.0 mg/ml; benzathine penicillin antibiotic-penicillin active 115.0 mg/ml - antibiotic & related - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - treatment of infection | penicillin sensitive organisms

Elanco Procaine Penicillin 30 New Zealand - English - Ministry for Primary Industries

elanco procaine penicillin 30

elanco new zealand - penicillin g procaine; penicillin g benzathine - penicillin g procaine 150 g/litre; penicillin g benzathine 150 g/litre - antibiotic

ULTRAPEN LA PROCAINE PENICILLIN INJECTION FOR CATTLE AND PIGS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ultrapen la procaine penicillin injection for cattle and pigs

norbrook laboratories australia pty limited - procaine penicillin - parenteral liquid/solution/suspension - procaine penicillin antibiotic-penicillin active 300.0 mg/ml - antibiotic & related - cattle | pigs | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | gilt | hei - treatment of infection | penicillin sensitive organisms

DEPOCILLIN PROCAINE PENICILLIN 300MG/ML INJECTION Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

depocillin procaine penicillin 300mg/ml injection

intervet australia pty limited - procaine penicillin - parenteral liquid/solution/suspension - procaine penicillin antibiotic-penicillin active 300.0 mg/ml - antibiotic & related - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - antibiotics - oral, parenteral | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | hypermotility | infected wounds | infections | lactating | mastitis | protozoal infections | pyometra | salmonellosis | sinusitis | systemic bacterial infection

BICILLIN L-A benzathine benzylpenicillin tetrahydrate 1,200,000 Units / 2.3 mL suspension for injection pre-filled syringe with needle Australia - English - Department of Health (Therapeutic Goods Administration)

bicillin l-a benzathine benzylpenicillin tetrahydrate 1,200,000 units / 2.3 ml suspension for injection pre-filled syringe with needle

pfizer australia pty ltd - benzathine benzylpenicillin tetrahydrate, quantity: 1200000 usp unit - injection, suspension - excipient ingredients: water for injections; sodium citrate; carmellose sodium; povidone; propyl hydroxybenzoate; methyl hydroxybenzoate; lecithin - intramuscular benzathine penicillin is indicated in the treatment of infections due to penicillin-sensitive micro-organisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. the following infections will usually respond to adequate dosage of intramuscular benzathine penicillin: streptococcal infections (group a - without bacteraemia). mild-to-moderate infections of the upper respiratory tract (e.g. pharyngitis). venereal infections - syphilis, yaws, bejel and pinta. medical conditions in which benzathine penicillin therapy is indicated as prophylaxis: rheumatic fever and/or chorea - prophylaxis with benzathine penicillin has proven effective in preventing recurrence of these conditions. it has also been used as a follow-up prophylactic therapy for preventing rheumatic heart disease and acute glomerulonephritis.

Benzathine Benzylpenicillin Injection Kenya - English - Pharmacy and Poisons Board

benzathine benzylpenicillin injection

benzathine penicillin bp 600,000 iu… - injection - benzathine penicillin bp 600,000 iu… - benzylpenicillin

Fortified Procaine Penicillin injection Powder For Injection Kenya - English - Pharmacy and Poisons Board

fortified procaine penicillin injection powder for injection

laboratory & allied ltd p.o box 42875 nairobi kenya. plot no. 209/10349 - procaine penicillin and benzylpenicillin (as… - powder for injection - procaine penicillin 3000000 i.u and… - combinations

BICILLIN L-A- penicillin g benzathine injection, suspension United States - English - NLM (National Library of Medicine)

bicillin l-a- penicillin g benzathine injection, suspension

pfizer laboratories div pfizer inc - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c) - penicillin g 600000 [iu] in 1 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin l-a and other antibacterial drugs, bicillin l-a should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. intramuscular penicillin g benzathine is indicated in the treatment of infections due to penicillin-g-sensitive microorganisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. the following infections will usually respond to adequate dosage of intramuscular penicillin g benzathine: mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci. venereal infections —syphilis, yaws, bejel, and pinta. medical conditions in which penicillin g benzathine therapy is indicated as prophylaxis: rheumatic fever and/or chorea —prophylaxis with penicillin g benzathine has proven effective in preventing recurrence of these conditions. it has also been used as follow-up prophylactic therapy for rheumatic heart disease and acute glomerulonephritis. a history of a previous hypersensitivity reaction to any of the penicillins is a contraindication.

BICILLIN CR- penicillin g benzathine and penicillin g procaine injection, suspension United States - English - NLM (National Library of Medicine)

bicillin cr- penicillin g benzathine and penicillin g procaine injection, suspension

pfizer laboratories div pfizer inc - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c), penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c) - penicillin g 600000 [iu] in 2 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin c-r and other antibacterial drugs, bicillin c-r should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is indicated in the treatment of moderately severe infections due to penicillin-g-susceptible microorganisms that are susceptible to serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response. bicillin c-r is indicated in the treatment of the following in adults and pediatric patients: moderately severe to severe infections of the upper-respiratory tract, scarlet fever, erysipelas, and skin and soft-tissue infections due to susceptible streptococci. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin g. other groups, including group d (enterococci), are resistant. penicillin g sodium or potassium is recommended for streptococcal infections with bacteremia. moderately severe pneumonia and otitis media due to susceptible streptococcus pneumoniae . note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, peritonitis, and arthritis of pneumococcal etiology are better treated with penicillin g sodium or potassium during the acute stage. when high, sustained serum levels are required, penicillin g sodium or potassium, either im or iv, should be used. this drug should not be used in the treatment of venereal diseases, including syphilis, gonorrhea, yaws, bejel, and pinta. a previous hypersensitivity reaction to any penicillin or to procaine is a contraindication.